The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival trends among patients diagnosed with both melanoma and chronic lymphocytic leukemia.
 
Yayi Zhao
No Relationships to Disclose
 
Rossybelle Amorrortu
No Relationships to Disclose
 
Sandra C. Stewart
No Relationships to Disclose
 
Kavita Ghia
No Relationships to Disclose
 
Vonetta L. Williams
No Relationships to Disclose
 
Vernon K. Sondak
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Iovance Biotherapeutics; Merck/Schering Plough; Novartis; Regeneron
Research Funding - Neogene Therapeutics (Inst); Turnstone Bio (Inst)
 
Kenneth Yee Tsai
Stock and Other Ownership Interests - Dimerix; NFlection Therapeutics
Consulting or Advisory Role - EMD Serono; NFLection Therapeutics; Sun Pharma
Research Funding - FORMA Therapeutics
Patents, Royalties, Other Intellectual Property - NFlection Therapeutics and Moffitt Cancer Center, John Kincaid, Kavita Sarin, Kenneth Y. Tsai, ARYL-ANILINE AND HETEROARYL-ANILINE COMPOUNDS FOR TREATMENT OF SKIN CANCERS, 046776-523P01US, 11/20/2019; UCSB, Samir Mitragotri, Byeong Hee Hwang, Nishit Doshi, Kenneth Tsai, Russell M. Lebovitz. COMPOSITIONS FOR SOLUBILIZING CELLS AND/OR TISSUE, United States, 13/432,978, 3/28/2012.
 
Javier Pinilla-Ibarz
Honoraria - Abbvie; AstraZeneca; Janssen; Novartis; Pharmacyclics; Takeda
Consulting or Advisory Role - Abbvie; Janssen; Novartis; Pharmacyclics
Speakers' Bureau - Abbvie; AstraZeneca; Pharmacyclics/Janssen; Takeda
Patents, Royalties, Other Intellectual Property - From a WT vaccine patent by Memorial Sloan Kettering Cancer Center
 
Julio C. Chavez
Consulting or Advisory Role - Abbvie; Janssen; Karyopharm Therapeutics; Kite/Gilead; MorphoSys; Novartis; TeneoBio
Speakers' Bureau - AstraZeneca; BeiGene; Epizyme; MorphoSys
Research Funding - Merck (Inst); Merck (Inst)
 
Dana Elise Rollison
Leadership - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
Research Funding - Flatiron Health
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a provisional patent application filed in July of 2020. The patent pertains to the use of spectrophotometer-measured ultraviolet radiation exposure in combination with regulatory T-cells measured in circulation to predict risk of sub
Travel, Accommodations, Expenses - Caserta; NanoString Technologies